• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 23, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Adults with disabilities screened less often for colorectal cancer

Bioengineer by Bioengineer
March 29, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Justin Kelley/MU Health

COLUMBIA, Mo. (March 29, 2017) — Colorectal cancer is the fourth most common type of cancer in the United States, with nearly 135,000 cases reported in 2016. The likelihood of surviving colorectal cancer is strongly related to the stage in which it is diagnosed. Researchers from the University of Missouri School of Medicine looked at screening adherence rates and found that individuals with certain disabilities are less likely to receive recommended preventive screenings. The researchers hope the finding will lead to targeted interventions and increased awareness for these individuals.

"Colorectal cancer is the second leading cause of cancer deaths in the U.S.," said Chelsea Deroche, Ph.D., assistant professor of biostatistics in the MU Department of Health Management and Informatics and in the Biostatistics and Research Design Unit. "However, almost 60 percent of these deaths could be prevented if people ages 50 years or older received routine screenings. When studying adherence rates to recommended screenings, we found that individuals with blindness or low vision, an intellectual disability or a spinal cord injury are less likely to receive screenings than those without these disabilities."

The U.S. Preventive Services Task Force currently recommends that individuals ages 50 to 75 be screened by one of the following methods:

  • fecal occult blood test every year;
  • sigmoidoscopy every five years, plus a fecal occult blood test every three years; or
  • colonoscopy every 10 years.

In their observational study, researchers reviewed data from South Carolina Medicaid and Medicare claims, state health plan claims and hospital discharge data between 2000 and 2009. The researchers compared colorectal screening adherence rates of individuals with either blindness or low vision, an intellectual disability or a spinal cord injury to the general U.S. population.

About 48 percent of the general population reported receiving routine screenings, compared to 34 percent of individuals with an intellectual disability, 44 percent of individuals with spinal cord injuries and 46 percent of individuals with blindness or low vision.

"These individuals may not be routinely screened for colorectal cancer due to a lack of education and awareness, transportation challenges or other barriers," Deroche said. "These findings support the need for increased awareness and targeted advocacy outreach efforts to both physicians and caregivers to ensure all individuals are screened appropriately."

###

The study, "Colorectal Cancer Screening Adherence in Selected Disabilities Over 10 Years," recently was published online in the American Journal of Preventive Medicine. Research reported in this publication was supported by the Centers for Disease Control and Prevention (U01 RFA-DD-12-006). The researchers have no conflicts of interest to declare related to this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agency.

About the MU School of Medicine

The MU School of Medicine has improved health, education and research in Missouri and beyond for more than 165 years. MU physicians treat patients from every county in the state, and more Missouri physicians received their medical degrees from MU than from any other university. For more information, visit http://medicine.missouri.edu/.

Media Contact

Derek Thompson
[email protected]
573-882-3323
@mizzounews

http://www.missouri.edu

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

Impact of Moderate Warming on Soil Microbial Decomposition

Impact of Moderate Warming on Soil Microbial Decomposition

August 23, 2025
Inside CNS Solitary Fibrous Tumors: Genetics and Therapies

Inside CNS Solitary Fibrous Tumors: Genetics and Therapies

August 23, 2025

Brain-Delivered Antibody Targets Alpha-Synuclein Aggregates

August 23, 2025

MOF-Enhanced Sn-Doped V2O5 Cathodes for Fast Lithium Storage

August 23, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Impact of Moderate Warming on Soil Microbial Decomposition

Inside CNS Solitary Fibrous Tumors: Genetics and Therapies

Brain-Delivered Antibody Targets Alpha-Synuclein Aggregates

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.